PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Jun-2024 New US headquarters opened by mass photometry pioneers Refeyn Refeyn
07-Jun-2024 16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs Conference marcus evans
07-Jun-2024 Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00 Medios AG
07-Jun-2024 Combined General Meeting of June 24, 2024 Biophytis
07-Jun-2024 Cannovum Cannabis AG: Bundestag confirms Cannovum Cannabis AG's business model for cultivation clubs, legal certainty for recreational cannabis producers Cannovum Cannabis AG
06-Jun-2024 Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO MorphoSys AG
06-Jun-2024 PM Society Digital Awards – 12th September 2024 - Tickets Now on Sale! PM Society
06-Jun-2024 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
06-Jun-2024 Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe Medios AG
06-Jun-2024 M1 Kliniken AG on a growth path with cutting-edge medicine: EBIT +70% in the first quarter of 2024 M1 Kliniken AG
06-Jun-2024 DEFENCE’S ACCUTOX PUBLISHED IN THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE ITS PEER STUDY WITH PRECLINICAL DATA ON ACCUTOX AS AN ANTI-CANCER MOLECULE Defence Therapeutics Inc.
05-Jun-2024 Newron Pharmaceuticals will host its 2024 Investor Day on June 25 in New York City Newron Pharmaceuticals S.p.A.
05-Jun-2024 Otsuka announces new results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in people with hereditary angioedema Otsuka Pharmaceutical Europe Ltd.
04-Jun-2024 QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments QUANTRO Therapeutics GmbH
04-Jun-2024 Cybersecurity Incident at Synnovis in UK SYNLAB AG
04-Jun-2024 Spexis launches appeal against SIX Exchange Regulation decision to suspend trading of its shares. Spexis AG
04-Jun-2024 Diversity and Inclusion Interest Group Survey PM Society
04-Jun-2024 Cannovum Cannabis AG: Cash capital increase from authorized capital with subscription rights Cannovum Cannabis AG
04-Jun-2024 APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned industry expert leads supply chain management APONTIS PHARMA AG
03-Jun-2024 Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 Mainz BioMed N.V.